These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22849686)

  • 1. Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene.
    Urbasic AS; Hynes S; Somrak A; Contakos S; Rahman MM; Liu J; MacNeill AL
    Am J Vet Res; 2012 Aug; 73(8):1252-61. PubMed ID: 22849686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.
    Stanford MM; Barrett JW; Nazarian SH; Werden S; McFadden G
    J Virol; 2007 Feb; 81(3):1251-60. PubMed ID: 17108021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.
    Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL
    Viruses; 2020 May; 12(5):. PubMed ID: 32397134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.
    MacNeill AL; Weishaar KM; Séguin B; Powers BE
    Viruses; 2018 Jul; 10(8):. PubMed ID: 30060548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.
    Wang G; Barrett JW; Stanford M; Werden SJ; Johnston JB; Gao X; Sun M; Cheng JQ; McFadden G
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4640-5. PubMed ID: 16537421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.
    Messud-Petit F; Gelfi J; Delverdier M; Amardeilh MF; Py R; Sutter G; Bertagnoli S
    J Virol; 1998 Oct; 72(10):7830-9. PubMed ID: 9733819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.
    Kim M; Williamson CT; Prudhomme J; Bebb DG; Riabowol K; Lee PW; Lees-Miller SP; Mori Y; Rahman MM; McFadden G; Johnston RN
    Oncogene; 2010 Jul; 29(27):3990-6. PubMed ID: 20473328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.
    Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A
    Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the Myxoma virus SERP2 P1-site to prevent proteinase inhibition causes apoptosis in cultured RK-13 cells and attenuates disease in rabbits, but mutation to alter specificity causes apoptosis without reducing virulence.
    MacNeill AL; Turner PC; Moyer RW
    Virology; 2006 Dec 5-20; 356(1-2):12-22. PubMed ID: 16959285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
    Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
    Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for the Construction of Recombinant Oncolytic Myxoma Viruses.
    Torres-Domínguez LE; de Matos AL; Rahman MM; McFadden G
    Methods Mol Biol; 2021; 2225():63-75. PubMed ID: 33108657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
    McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA
    Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells.
    Turner PC; Sancho MC; Thoennes SR; Caputo A; Bleackley RC; Moyer RW
    J Virol; 1999 Aug; 73(8):6394-404. PubMed ID: 10400732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential bat adenovirus-based oncolytic virus targeting canine cancers.
    Matsugo H; Kitamura-Kobayashi T; Kamiki H; Ishida H; Sekine W; Takenaka-Uema A; Nakagawa T; Murakami S; Horimoto T
    Sci Rep; 2021 Aug; 11(1):16706. PubMed ID: 34408176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cell signaling in poxvirus tropism: the case of the M-T5 host range protein of myxoma virus.
    Werden SJ; McFadden G
    Biochim Biophys Acta; 2008 Jan; 1784(1):228-37. PubMed ID: 17905673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits.
    Stanford MM; Barrett JW; Gilbert PA; Bankert R; McFadden G
    J Virol; 2007 Nov; 81(22):12704-8. PubMed ID: 17728229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy.
    Adelfinger M; Bessler S; Frentzen A; Cecil A; Langbein-Laugwitz J; Gentschev I; Szalay AA
    Viruses; 2015 Jul; 7(7):4075-92. PubMed ID: 26205404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.
    Barrett JW; Alston LR; Wang F; Stanford MM; Gilbert PA; Gao X; Jimenez J; Villeneuve D; Forsyth P; McFadden G
    J Neurovirol; 2007 Dec; 13(6):549-60. PubMed ID: 18097886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma.
    Josiah DT; Zhu D; Dreher F; Olson J; McFadden G; Caldas H
    Mol Ther; 2010 Feb; 18(2):377-85. PubMed ID: 19904233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.
    Stanford MM; McFadden G
    Expert Opin Biol Ther; 2007 Sep; 7(9):1415-25. PubMed ID: 17727330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.